MRI Evaluation of Graft Maturation Following ACL Reconstruction
ConditionACL Tears
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age14-50
SponsorSkye Biologics Holdings, LLC
About this trial
Post-surgical ACL Graft maturation will be assessed at 4.5, 6, 7.5, 9, 10.5, and 12 months with MRI.
Eligibility criteria
Qualifiers
ACL tear and reconstruction; no other knee ligaments needing reconstruction
Primary (first-time) ACL tear in the affected knee
ACL injury occurred less than 12 months before ACL reconstruction
Have no contraindications or allergies to the treatment administered
Disqualifiers
Prior surgery on the index knee within 12 months of enrollment
Steroid injection into the index knee within 6 weeks of enrollment
Chronic ACL tear whereas the injury occurred more than 12 months ago
Multiligamentous injuries whereas any ligament (MCL, PCL, or PLC) in addition to the ACL needs to be reconstructed
Trial design
Treatments tested in this trial
- MRI
Treatment groups
10 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov